FDA Investigator Kelly N Kerr

Kelly N Kerr has conducted inspections on 47 sites in 1 countries as of 30 Aug 2021. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
47
Last Inspection Date:
30 Aug 2021
Investigator Role:
FDA Investigator
Redica ID:
100001064
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Kelly N Kerr:
Abdellah El Hajjam, Adetutu M Gidado, Akbar J Zaidi, Albert A Salvador, Alla Kachko, PhD, Anastasia I Offordile, Anastasia I Onuorah, Anissa M Cheung, Anita R Michael, Ann L Demarco, Ann Marie Karnick, Ann Marie Montemurro, Ann Marie Schofield, Anthony A Charity, Audrey Thereset Uy, Brandi L Garbutt, Brandon J Brookens, Brentley S Collins, Brian S Keefer, Calvin W Edwards, Cara M Minelli, CDR Jeremy L Wally, PhD, CDR Michael J Mero, Chao Ming Tsai, Charles L Larson, Christian D Lynch (CDL), Christina J Sauder, PhD, Christopher Bastedo, Christopher J Adams, Craig D Zagata, Cynthia Jim, CSO, Daniel R Tammariello, Daniel T Lee, Dauksism, Dave Hafner, David A Oluwo, David J Hafner, David L Pearce, Debra J Bennett, Debra L Pagano, Don A Leeseberg, Dr. Mark J Seaton, PhD, Edward D Mcdonald, Eileen A Liu, Elisa M Fleming, Ellen Huang, Eric S Myskowski, Gabrielle J Swain, Gayle S Lawson, Gene D Arcy, George C Amedro, Hala L Selby, Haruhiko Murata, Helen B Ricalde, J David Doleski, Jacob M Dyer, Jacqueline Mdiaz Albertini, James M Mason, James P Mcevoy, Jeffrey R Wooley, Joan A Loreng, Joan Adamo, Joanne M Hajoway, Joanne M Schlossin, Joseph George, Joseph L Despins, PhD, Joshua J Silvestri, Julianne C Mccullough, Junho Pak, Karyn M Campbell, Kathleen B Mihalik, Kathryn Carbone, MD, Kenneth M Gordon, Kimberly A Dux, Kristen D Evans, Kristina J Donohue, Kristina Mjoyce Pittman, LCDR Margaret Edi Gennaro, Linda Thai, Lisa M Bellows, Lisa M Feola, LT John M Mastalski, LTJG Bradley E Benasutti, Marcelo O Mangalindan, Jr, Marian E Major, PhD, Maureen A Wentzel, Melissa M Dauksis, Michael Curbarg, Michael F Skelly, PhD, Michael Gurbarg, Michael J Nerz, Michele M Falchek, Mihaly S Ligmond, Mike M Rashti, Nina Yang, Oleg Vesnovsky, Omotunde O Osunsanmi, Paula A Trost, Prabhu P Raju, Ramon E Martinez, Rebecca K Olin, Robert B Shibuya, MD, Robert D Tollefsen, Rose Ashley, Saijal P Naik, Scott E Norris, Sean D Duke, Sheila Dreher Lesnick, Shelley L Waring, Shuang Tang, Shusheen A Alexander, Simone E Pitts, Stephanie Mangigian, MS/OSH, RN, Stephen D Brown, Steven A Rubin, Steven E Kane, Susan F Laska, MS, Suzie L Kent, Tammy L Chavis, Thomas E Friel, Timothy J Schmidt, Tina S Roecklein, Toyin B Oladimeji, Vivian Garcia, Vlada Matusovsky, Wei Wang, PhD, William C Brenneman, Xiao Wang

Kelly N Kerr's Documents

Publish Date Document Type Title
June, 2016 FDA 483 Stephen M. Schleicher, M.D. - Form 483, 2016-06-28
February, 2019 FDA 483 Thomas Jefferson University IRB - Form 483, 2019-02-15
October, 2019 FDA 483 Paul R. Sieber, M.D. - Form 483, 2019-10-23
September, 2018 FDA 483 Lawrence Levinson, M.D. - Form 483, 2018-09-06
July, 2018 EIR Calvert Laboratories, Inc. - EIR, 2018-07-25
January, 2021 FDA 483 DERMDOX CENTERS FOR DERMATOLOGY - Form 483, 2021-01-21
April, 2017 FDA 483 Pennsylvania State University IRB - Form 483, 2017-04-26
February, 2019 FDA 483 Response Thomas Jefferson University IRB - Form 483R, 2019-02-27
March, 2018 FDA 483 UPMC Susquehanna - Form 483, 2018-03-29
April, 2019 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2019-04-30
July, 2019 FDA 483 Ram K. Shrivastava, M.D. - Form 483, 2019-07-26
September, 2020 FDA 483 Sigrid Blome-Eberwein - Form 483, 2020-09-28
February, 2019 EIR Thomas Jefferson University IRB - EIR, 2019-02-15
November, 2018 EIR Genus Lifesciences Inc. - EIR, 2018-11-28

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more